This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INDEPENDENT_MULTIPLE_SITES_NAS_EXALLC for full statistics.
Malignant neoplasms of independent (primary) multiple sites
CD2_INDEPENDENT_MULTIPLE_SITES_NAS
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
14
Check minimum number of events None
14
Include endpoints None
14
Remove individuals based on genotype QC
14
CD2_INDEPENDENT_MULTIPLE_SITES_NAS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
C97-C97
Name in latin
Neoplasmata maligna locis multis non dependentibus (primariis)
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasms of independent (primary) multiple sites
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasms of independent (primary) multiple sites (controls excluding all cancers)
- Malignant neoplasms of independent (primary) multiple sites
- Malignant neoplasms of independent (primary) multiple sites (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 14 | 6 | 8 |
| Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
| Mean age at first event (years) | 60.01 | 51.43 | 66.44 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INDEPENDENT_MULTIPLE_SITES_NAS – Malignant neoplasms of independent (primary) multiple sites
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasms of independent (primary) multiple sites
↥Endpoint not on priority list, no data to show.